Abstract
Compositions comprising at least one of miR that down regulates PD-L1/PD-1, MSCs expressing same, or exosomes from those MSCs are provided. Methods of decreasing PD-L1 expression, PD-1 expression or both and treating PD-L1 positive cancers using same are also provided.
Original language | English |
---|---|
Patent number | US20210260141A1 |
State | Published - 26 Aug 2021 |